"The proportion of JN.1 continues to increase more rapidly than other variants... Based on laboratory data, existing vaccines, tests, and treatments work against JN.1."
"The variant JN.1 is not exactly new... There is no data to support whether JN.1 poses an increased risk or severity of illness, the agency said. It's also too early to tell if the variant causes any unique symptoms."
[
add
]
[
|
|
...
]